Stay updated on Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page.

Latest updates to the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page’s footer revision label was updated from **v3.5.2** to **v3.5.3**, indicating a minor ClinicalTrials.gov site/version update rather than a change to the recorded trial information.SummaryDifference0.1%

- Check23 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check67 days agoChange DetectedNew revision v3.4.3 was added to the history and revision v3.4.2 was removed.SummaryDifference0.1%

- Check88 days agoChange DetectedA new revision entry v3.4.2 appears in the page history, replacing the previous v3.4.1. This reflects a minor metadata update to the page history.SummaryDifference0.1%

- Check95 days agoChange Detected- A new revision entry v3.4.1 was added to the history, and the previous v3.4.0 entry was removed.SummaryDifference0.1%

Stay in the know with updates to Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page.